Across TCGA cell cohorts, OR2T2 RNA expression is significantly associated with the mutation status of many other genes, with 75 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible OR2T2-associated genes across cancer lineages are PKHD1, REV3L, and CPAMD8. Each is linked with OR2T2 in more than 1 cancer types. Because this analysis shows association rather than direction, both OR2T2-to-partner and partner-to-OR2T2 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR2T2→partner) and Y-score (partner→OR2T2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BREAST	PKHD1 →	+2.584	+0.005	.007	.001	3	2
CNS	REV3L →	+4.357	+0.011	.004	<.001	3	2
BLOOD_Lymphoma	CPAMD8 →	+3.855	+0.144	.003	.001	3	2
BLOOD_Leukemia	STK11IP →	+3.536	+0.192	.001	<.001	3	2
BLOOD_Myeloma	HEPHL1 →	+3.754	+0.202	.002	.006	3	1
BLOOD_Myeloma	GEMIN5 →	+3.754	+0.202	.002	.006	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 75 associations by consensus.

Exploration

OR2T2 survival (RNA) · tumor vs normal (RNA) · all OR2T2 data types